DCGI seeks more data from SII over its application seeking emergency authorisation for Covovax, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Serum Institute of India (SII) had sent an application to the DCGI in October for the grant of market authorisation of Covovax for restricted use in emergency situations., Serum Institute of India (SII) had sent an application to the DCGI in October for the grant of market authorisation of Covovax for restricted use in emergency situations., , Read More